{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:53:26Z","timestamp":1767135206128,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd012064","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T00:00:00Z","timestamp":1552694400000}}],"reference-count":37,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012064.pub2","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T13:43:37Z","timestamp":1552916617000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Hydroxyurea (hydroxycarbamide) for transfusion-dependent \u03b2-thalassaemia"],"prefix":"10.1002","author":[{"given":"Saqib H","family":"Ansari","sequence":"first","affiliation":[{"name":"National Institute of Blood Disease & Bone Marrow Transplant; Department of Pediatric Hematology and Oncology; ST 2\/A Block 17 Gulshan-e-Iqbal, KDA Scheme 24 Karachi Sindh Pakistan 75300"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohra S","family":"Lassi","sequence":"additional","affiliation":[{"name":"The University of Adelaide; The Robinson Research Institute; Adelaide South Australia Australia 5005"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salima M","family":"Khowaja","sequence":"additional","affiliation":[{"name":"Omair Sana Foundation; Research Department; Flat B25, Al-Qayam Housing Society Al-fred Street, Garden West Karachi Sindh Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Omair","family":"Adil","sequence":"additional","affiliation":[{"name":"Omair Sana Foundation; Research Department; Flat B25, Al-Qayam Housing Society Al-fred Street, Garden West Karachi Sindh Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahir S","family":"Shamsi","sequence":"additional","affiliation":[{"name":"National Institute of Bone Disease & Bone Marrow Transplant; ST 2\/A Block 17 Gulshan-e-Iqbal, KDA Scheme 24 Karachi Sindh Pakistan 75300"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,3,16]]},"reference":[{"issue":"7","key":"10.1002\/14651858.CD012064.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00277-003-0836-5","article-title":"Hydroxyurea in the treatment of major beta-thalassemia and importance of genetic screening","volume":"83","author":"Alebouyeh","year":"2004","journal-title":"Annals of Hematology"},{"issue":"13","key":"10.1002\/14651858.CD012064.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1056\/NEJM199703273361318","article-title":"Letter to the Editor. Successful use of hydroxyurea in \u03b2-thalassemia major","volume":"336","author":"Arruda","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012064.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5812\/ircmj.18028","article-title":"Hydroxyurea treatment in transfusion-dependent \u03b2-thalassemia patients","volume":"16","author":"Bordbar","year":"2014","journal-title":"Iranian Red Crescent Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD012064.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1529-30","DOI":"10.1182\/blood-2003-01-0117","article-title":"Hydroxyurea can eliminate transfusion requirements in children with severe beta-thalassemia","volume":"102","author":"Bradai","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1002\/14651858.CD012064.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1537-2995.2007.01399.x","article-title":"Decreases transfusion need associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia","volume":"47","author":"Bradai","year":"2007","journal-title":"Transfusion"},{"issue":"1-2","key":"10.1002\/14651858.CD012064.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cca.2009.06.019","article-title":"Response to hydroxyurea in beta thalassemia major and intermedia: experience in western India","volume":"407","author":"Italia","year":"2009","journal-title":"Clinica Chimica Acta"},{"key":"10.1002\/14651858.CD012064.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"120-8","DOI":"10.1111\/j.1749-6632.1998.tb10469.x","article-title":"Hydroxurea therapy in thalassemia","volume":"850","author":"Loukopoulos","year":"1998","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD012064.pub2-BIB0008|cit8","unstructured":"NCT00809042 Combination Therapy of Hydroxyurea With L-Carnitine and Magnesium Chloride in Thalassemia Intermedia www.clinicaltrials.gov\/show\/NCT00809042"},{"key":"10.1002\/14651858.CD012064.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1749-6632.1998.tb10467.x","article-title":"Elimination of transfusions through induction of fetal hemoglobin synthesis in Cooley\u2019s anemia","volume":"850","author":"Olivieri","year":"1998","journal-title":"Annals New York Academy of Sciences"},{"key":"10.1002\/14651858.CD012064.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1749-6632.1998.tb10520.x","article-title":"Increase in hemoglobin concentration during therapy with hydroxyurea in Cooley\u2019s anemia","volume":"850","author":"Saxon","year":"1998","journal-title":"Annals New York Academy of Sciences"},{"issue":"3","key":"10.1002\/14651858.CD012064.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2141.1995.tb08352.x","article-title":"Clinical and laboratory effects of long-term administration of hydroxyurea to patients with sickle-cell\/b-thalassaemia","volume":"89","author":"Voskaridou","year":"1995","journal-title":"British Journal of Hematology"},{"issue":"10","key":"10.1002\/14651858.CD012064.pub2-BIB0012|cit12","first-page":"1172","article-title":"Response to hydroxyurea treatment in Iranian transfusion-dependent b-thalassemia patients","volume":"89","author":"Yavarian","year":"2004","journal-title":"Haematologica"},{"issue":"3","key":"10.1002\/14651858.CD012064.pub2-BIB0013|cit13","first-page":"295","article-title":"Hydroxyurea therapy in 49 patients with major beta-thalassemia","volume":"12","author":"Zamani","year":"2009","journal-title":"Archives of Iranian Medicine"},{"key":"10.1002\/14651858.CD012064.pub2-BIB0014|cit14","unstructured":"NCT03183375 The Efficacy and Safety of HYDROXYUREA in Management of Beta Thalassemia Patients in Karachi Pakistan www.clinicaltrials.gov\/show\/NCT03183375"},{"key":"10.1002\/14651858.CD012064.pub2-BIB0015|cit15","unstructured":"SLCTR\/2018\/024 Effectiveness of hydroxyurea treatment compared to placebo in reducing transfusions in beta-thalassaemia patients www.slctr.lk\/trials\/1286"},{"issue":"11","key":"10.1002\/14651858.CD012064.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/MPH.0b013e318157fd75","article-title":"Efficacy of hydroxyurea (HU) in reduction of pack red cell (PRC) transfusion requirement among children having beta-thalassemia major: Karachi HU trial (KHUT)","volume":"29","author":"Ansari","year":"2007","journal-title":"Journal of Pediatric Hematology Oncology"},{"issue":"5","key":"10.1002\/14651858.CD012064.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MPH.0b013e31821b0770","article-title":"Efficacy of hydroxyurea in providing transfusion independence in \u03b2-thalassemia","volume":"33","author":"Ansari","year":"2011","journal-title":"Journal of Pediatric Hematology Oncology"},{"issue":"3","key":"10.1002\/14651858.CD012064.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1586\/ehm.11.29","article-title":"Complications of thalassemia major and their treatment","volume":"4","author":"Borgna","year":"2011","journal-title":"Expert Review Hematology"},{"issue":"3","key":"10.1002\/14651858.CD012064.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"887-92","DOI":"10.1182\/blood.V87.3.887.bloodjournal873887","article-title":"Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in \u03b2-thalassemia\/Hemoglobin E disease","volume":"87","author":"Fucharoen","year":"1996","journal-title":"Blood"},{"key":"10.1002\/14651858.CD012064.pub2-BIB0020|cit20","first-page":"571","article-title":"When to believe a subgroup analysis","volume-title":"The Users\u2019 Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice","author":"Guyatt","year":"2008"},{"key":"10.1002\/14651858.CD012064.pub2-BIB0021|cit21","unstructured":"Higgins JPT Altman DG Sterne JAC editor(s) on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012064.pub2-BIB0022|cit22","unstructured":"Higgins JPT Deeks JJ Altman DG editor(s) on behalf of the Cochrane Statistical Methods Group Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012064.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0140-6736(11)60283-3","article-title":"Thalassemia","volume":"379","author":"Higgs","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD012064.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12185-011-0985-6","article-title":"Genotype-phenotype relationship of patients with \u03b2-thalassemia taking hydroxyurea: a 13-year experience in Iran","volume":"95","author":"Karimi","year":"2012","journal-title":"International Journal of Hematology"},{"issue":"5","key":"10.1002\/14651858.CD012064.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ajh.21120","article-title":"Response to hydroxyurea therapy in beta-thalassemia","volume":"83","author":"Koren","year":"2008","journal-title":"American Journal of Hemataology"},{"key":"10.1002\/14651858.CD012064.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2471\/BLT.06.036673","article-title":"Global epidemiology of haemoglobin disorders and derived service indicators","volume":"86","author":"Modell","year":"2008","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD012064.pub2-BIB0027|cit27","unstructured":"UK National Steering Committee Sickle cell and thalassaemia screening programme: standards for the linked antenatal and newborn screening program http:\/\/sct.screening.nhs.uk\/standardsandguidelines"},{"key":"10.1002\/14651858.CD012064.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1182\/asheducation-2005.1.38","article-title":"Fetal globin induction can it cure beta thalassemia?","volume":"2005 no.1","author":"Perrine","year":"2005","journal-title":"Hematology. American Society of Hematology. Education Program"},{"issue":"5","key":"10.1002\/14651858.CD012064.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3324\/haematol.2012.074492","article-title":"Hydroxyurea responsiveness in \u03b2-thalassemic patients is determined by the stress response adaptation of erythroid progenitors and their differentiation propensity","volume":"98","author":"Pourfarzad","year":"2013","journal-title":"Haematologica"},{"issue":"13","key":"10.1002\/14651858.CD012064.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1182\/blood-2010-08-300335","article-title":"How I treat thalassemia","volume":"118","author":"Rachmilewitz","year":"2011","journal-title":"Blood"},{"key":"10.1002\/14651858.CD012064.pub2-BIB0031|cit31","unstructured":"Royal College of Obstetricians and Gynaecologists New guideline for managing thalassaemia in pregnancy announced at the RCOG World Congress in India www.rcog.org.uk\/en\/news\/new-guideline-for-managing-thalassaemia-in-pregnancy-announced-at-the-rcog-world-congress-in-india\/"},{"issue":"2","key":"10.1002\/14651858.CD012064.pub2-BIB0032|cit32","first-page":"55","article-title":"Beta thalassemia prevention and Pakistan: review article","volume":"35","author":"Rehman","year":"2011","journal-title":"Pakistan Paediatric Journal"},{"key":"10.1002\/14651858.CD012064.pub2-BIB0033|cit33","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"2","key":"10.1002\/14651858.CD012064.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12288-011-0057-3","article-title":"Blood transfusion transmissible infections in multiple blood transfused patients of beta thalassemia","volume":"27","author":"Vidja","year":"2011","journal-title":"Indian Journal of Hematology and Blood Transfusion"},{"issue":"2","key":"10.1002\/14651858.CD012064.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.13181\/mji.v16i2.259","article-title":"Hydroxyurea appears beneficial in patients with beta-thalassaemia major and intermedia","volume":"16","author":"Wahid","year":"2007","journal-title":"Medical Journal of Indonesia"},{"key":"10.1002\/14651858.CD012064.pub2-BIB0036|cit36","first-page":"1","article-title":"Thalassemias","volume-title":"Encylopedia of Life Sciences","author":"Weatherall","year":"2001"},{"issue":"3","key":"10.1002\/14651858.CD012064.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2141.1995.tb05584.x","article-title":"Hydroxyurea therapy in beta-thalassemia intermedia: improvement in hematological parameters due to enhanced beta-globin synthesis","volume":"90","author":"Zeng","year":"1995","journal-title":"British Journal of Haematology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012064.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T19:02:35Z","timestamp":1628535755000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD012064.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,3,16]]},"references-count":37,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012064.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,16]]}}}